Home > Healthcare & Medical Devices > Hemophilia Treatment Market > Table of Contents

Hemophilia Treatment Market Size By Disease (Hemophilia A {Severe, Moderate, Mild}, Hemophilia B {Severe, Moderate, Mild}), By Product (Recombinant Factor Concentrates {Factor VIII, Factor IX}, Plasma-derived Factor Concentrates {Factor VIII, Factor IX}, Extended Half-life Products {Factor VIII, Factor IX}), By Patient (Pediatric {0 to 4, 5 to 13, 14 to18}, Adult {19 to 44, 45+}), By Treatment (Prophylaxis, On Demand), By Therapy (Factor Replacement Therapy, Non-factor Replacement Therapy), By Drug Class (Vasopressin, Coagulation Factors), By Route of Administration (Injectable, Nasal Spray), By End-use (Hospitals, Clinics, Hemophilia Treatment Centers), Industry Analysis Report, Regional Outlook, Application Potential, Covid-19 Impact Analysis, Price Trends, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI2772
  • Published Date: Feb 2022
  • Report Format: PDF

Report Content

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates & working

1.3    Forecast calculations

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Hemophilia treatment industry 3600 synopsis, 2017- 2028

2.1.1    Business trends

2.1.2    Disease trends

2.1.3    Product trends

2.1.4    Patient trends

2.1.5    Treatment trends

2.1.6    Therapy trends

2.1.7    Drug class trends

2.1.8    Route of administration trends

2.1.9    End-use trends

2.1.10    Regional trends

Chapter 3   Hemophilia Treatment Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 - 2028 (USD Million)

3.3    Industry impact factors

3.3.1    Growth drivers

3.3.1.1    Growing prevalence of hemophilia across the globe

3.3.1.2    Rise in favourable government initiatives

3.3.1.3    Increase in R&D and new product development

3.3.1.4    Growing adoption of prophylaxis treatment

3.3.1.5    Upsurge in hemophilia prevalence in new-borns

3.3.1.6    Introduction of new drug launches

3.3.1.7    Rise in hemophilia inhibitors

3.3.2    Industry pitfalls & challenges

3.3.2.1    High cost associated with hemophilia treatment

3.3.2.2    Lack of awareness in developing and under-developed regions

3.3.2.3    Low adoption rates of technologically advanced products

3.4    Growth potential analysis

3.4.1    By disease

3.4.2    By product

3.4.3    By patient

3.4.4    By treatment

3.4.5    By therapy

3.4.6    By drug class

3.4.7    By route of administration

3.4.8    By end-use

3.5    COVID-19 impact analysis

3.6    Porter’s analysis

3.7    Competitive landscape, 2021

3.7.1    Competitive matrix analysis, 2021

3.8    PESTEL analysis

Chapter 4   Hemophilia Treatment Market, By Disease

4.1    Key segment trends

4.2    Hemophilia A

4.2.1    Market size, by region, 2017 - 2028 (USD Million)

4.2.2    Severe

4.2.2.1    Market size, by region, 2017 - 2028 (USD Million)

4.2.3    Moderate

4.2.3.1    Market size, by region, 2017 - 2028 (USD Million)

4.2.4    Mild

4.2.4.1    Market size, by region, 2017 - 2028 (USD Million)

4.3    Hemophilia B

4.3.1    Market size, by region, 2017 - 2028 (USD Million)

4.3.2    Severe

4.3.2.1    Market size, by region, 2017 - 2028 (USD Million)

4.3.3    Moderate

4.3.3.1    Market size, by region, 2017 - 2028 (USD Million)

4.3.4    Mild

4.3.4.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 5   Hemophilia Treatment Market, By Product

5.1    Key segment trends

5.2    Recombinant Factor Concentrates

5.2.1    Market size, by region, 2017 - 2028 (USD Million)

5.2.2    Factor VIII

5.2.2.1    Market size, by region, 2017 - 2028 (USD Million)

5.2.3    Factor IX

5.2.3.1    Market size, by region, 2017 - 2028 (USD Million)

5.3    Plasma-derived Factor Concentrates

5.3.1    Market size, by region, 2017 - 2028 (USD Million)

5.3.2    Factor VIII

5.3.2.1    Market size, by region, 2017 - 2028 (USD Million)

5.3.3    Factor IX

5.3.3.1    Market size, by region, 2017 - 2028 (USD Million)

5.4    Extended Half-life Products

5.4.1    Market size, by region, 2017 - 2028 (USD Million)

5.4.2    Factor VIII

5.4.2.1    Market size, by region, 2017 - 2028 (USD Million)

5.4.3    Factor IX

5.4.3.1    Market size, by region, 2017 - 2028 (USD Million)

5.5    Others

5.5.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 6   Hemophilia Treatment Market, By Patient

6.1    Key segment trends

6.2    Pediatric

6.2.1    Market size, by region, 2017 - 2028 (USD Million)

6.2.2    0 to 4 years

6.2.2.1    Market size, by region, 2017 - 2028 (USD Million)

6.2.3    5 to 13 years

6.2.3.1    Market size, by region, 2017 - 2028 (USD Million)

6.2.4    14 to 18 years

6.2.4.1    Market size, by region, 2017 - 2028 (USD Million)

6.3    Adult

6.3.1    Market size, by region, 2017 - 2028 (USD Million)

6.3.2    19 to 44

6.3.2.1    Market size, by region, 2017 - 2028 (USD Million)

6.3.3    45+

6.3.3.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 7   Hemophilia Treatment Market, By Treatment

7.1    Key segment trends

7.2    Prophylaxis

7.2.1    Market size, by region, 2017 - 2028 (USD Million)

7.3    On Demand

7.3.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 8   Hemophilia Treatment Market, By Therapy

8.1    Key segment trends

8.2    Factor Replacement Therapy

8.2.1    Market size, by region, 2017 - 2028 (USD Million)

8.3    Non-factor Replacement Therapy

8.3.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 9   Hemophilia Treatment Market, By Drug Class

9.1    Key segment trends

9.2    Vasopressin

9.2.1    Market size, by region, 2017 - 2028 (USD Million)

9.3    Coagulation Factors

9.3.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 10   Hemophilia Treatment Market, By Route of Administration

10.1    Key segment trends

10.2    Injectable

10.2.1    Market size, by region, 2017 - 2028 (USD Million)

10.3    Nasal Spray

10.3.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 11   Hemophilia Treatment Market, By End-use

11.1    Key segment trends

11.2    Hospitals

11.2.1    Market size, by region, 2017 - 2028 (USD Million)

11.3    Clinics

11.3.1    Market size, by region, 2017 - 2028 (USD Million)

11.4    Hemophilia Treatment Centers

11.4.1    Market size, by region, 2017 - 2028 (USD Million)

11.5    Others

11.5.1    Market size, by region, 2017 - 2028 (USD Million)

Chapter 12   Hemophilia Treatment Market, By Region

12.1    Key regional trends

12.2    North America

12.2.1    Market size, by country, 2017 - 2028 (USD Million)

12.2.2    Market size, by disease, 2017 - 2028 (USD Million)

12.2.2.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.2.2.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.2.3    Market size, by product, 2017 - 2028 (USD Million)

12.2.3.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.2.3.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.2.3.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.2.4    Market size, by patient, 2017 - 2028 (USD Million)

12.2.4.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.2.4.2    Market size, by adult, 2017 - 2028 (USD Million)

12.2.5    Market size, by treatment, 2017 - 2028 (USD Million)

12.2.6    Market size, by therapy, 2017 - 2028 (USD Million)

12.2.7    Market size, by drug class, 2017 - 2028 (USD Million)

12.2.8    Market size, by route of administration, 2017 - 2028 (USD Million)

12.2.9    Market size, by end-use, 2017 - 2028 (USD Million)

12.2.10    U.S.

12.2.10.1    Market size, by disease, 2017 - 2028 (USD Million)

12.2.10.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.2.10.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.2.10.2    Market size, by product, 2017 - 2028 (USD Million)

12.2.10.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.2.10.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.2.10.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.2.10.3    Market size, by patient, 2017 - 2028 (USD Million)

12.2.10.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.2.10.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.2.10.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.2.10.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.2.10.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.2.10.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.2.10.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.2.11    Canada

12.2.11.1    Market size, by disease, 2017 - 2028 (USD Million)

12.2.11.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.2.11.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.2.11.2    Market size, by product, 2017 - 2028 (USD Million)

12.2.11.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.2.11.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.2.11.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.2.11.3    Market size, by patient, 2017 - 2028 (USD Million)

12.2.11.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.2.11.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.2.11.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.2.11.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.2.11.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.2.11.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.2.11.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.3    Europe

12.3.1    Market size, by country, 2017 - 2028 (USD Million)

12.3.2    Market size, by disease, 2017 - 2028 (USD Million)

12.3.2.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.3.2.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.3.3    Market size, by product, 2017 - 2028 (USD Million)

12.3.3.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.3.3.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.3.3.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.3.4    Market size, by patient, 2017 - 2028 (USD Million)

12.3.4.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.3.4.2    Market size, by adult, 2017 - 2028 (USD Million)

12.3.5    Market size, by treatment, 2017 - 2028 (USD Million)

12.3.6    Market size, by therapy, 2017 - 2028 (USD Million)

12.3.7    Market size, by drug class, 2017 - 2028 (USD Million)

12.3.8    Market size, by route of administration, 2017 - 2028 (USD Million)

12.3.9    Market size, by end-use, 2017 - 2028 (USD Million)

12.3.10    Germany

12.3.10.1    Market size, by disease, 2017 - 2028 (USD Million)

12.3.10.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.3.10.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.3.10.2    Market size, by product, 2017 - 2028 (USD Million)

12.3.10.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.3.10.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.3.10.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.3.10.3    Market size, by patient, 2017 - 2028 (USD Million)

12.3.10.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.3.10.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.3.10.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.3.10.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.3.10.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.3.10.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.3.10.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.3.11    UK

12.3.11.1    Market size, by disease, 2017 - 2028 (USD Million)

12.3.11.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.3.11.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.3.11.2    Market size, by product, 2017 - 2028 (USD Million)

12.3.11.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.3.11.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.3.11.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.3.11.3    Market size, by patient, 2017 - 2028 (USD Million)

12.3.11.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.3.11.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.3.11.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.3.11.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.3.11.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.3.11.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.3.11.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.3.12    France

12.3.12.1    Market size, by disease, 2017 - 2028 (USD Million)

12.3.12.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.3.12.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.3.12.2    Market size, by product, 2017 - 2028 (USD Million)

12.3.12.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.3.12.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.3.12.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.3.12.3    Market size, by patient, 2017 - 2028 (USD Million)

12.3.12.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.3.12.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.3.12.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.3.12.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.3.12.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.3.12.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.3.12.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.3.13    Spain

12.3.13.1    Market size, by disease, 2017 - 2028 (USD Million)

12.3.13.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.3.13.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.3.13.2    Market size, by product, 2017 - 2028 (USD Million)

12.3.13.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.3.13.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.3.13.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.3.13.3    Market size, by patient, 2017 - 2028 (USD Million)

12.3.13.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.3.13.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.3.13.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.3.13.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.3.13.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.3.13.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.3.13.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.3.14    Italy

12.3.14.1    Market size, by disease, 2017 - 2028 (USD Million)

12.3.14.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.3.14.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.3.14.2    Market size, by product, 2017 - 2028 (USD Million)

12.3.14.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.3.14.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.3.14.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.3.14.3    Market size, by patient, 2017 - 2028 (USD Million)

12.3.14.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.3.14.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.3.14.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.3.14.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.3.14.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.3.14.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.3.14.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.4    Asia Pacific

12.4.1    Market size, by country, 2017 - 2028 (USD Million)

12.4.2    Market size, by disease, 2017 - 2028 (USD Million)

12.4.2.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.4.2.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.4.3    Market size, by product, 2017 - 2028 (USD Million)

12.4.3.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.4.3.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.4.3.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.4.4    Market size, by patient, 2017 - 2028 (USD Million)

12.4.4.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.4.4.2    Market size, by adult, 2017 - 2028 (USD Million)

12.4.5    Market size, by treatment, 2017 - 2028 (USD Million)

12.4.6    Market size, by therapy, 2017 - 2028 (USD Million)

12.4.7    Market size, by drug class, 2017 - 2028 (USD Million)

12.4.8    Market size, by route of administration, 2017 - 2028 (USD Million)

12.4.9    Market size, by end-use, 2017 - 2028 (USD Million)

12.4.10    China

12.4.10.1    Market size, by disease, 2017 - 2028 (USD Million)

12.4.10.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.4.10.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.4.10.2    Market size, by product, 2017 - 2028 (USD Million)

12.4.10.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.4.10.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.4.10.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.4.10.3    Market size, by patient, 2017 - 2028 (USD Million)

12.4.10.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.4.10.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.4.10.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.4.10.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.4.10.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.4.10.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.4.10.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.4.11    Japan

12.4.11.1    Market size, by disease, 2017 - 2028 (USD Million)

12.4.11.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.4.11.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.4.11.2    Market size, by product, 2017 - 2028 (USD Million)

12.4.11.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.4.11.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.4.11.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.4.11.3    Market size, by patient, 2017 - 2028 (USD Million)

12.4.11.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.4.11.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.4.11.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.4.11.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.4.11.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.4.11.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.4.11.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.4.12    India

12.4.12.1    Market size, by disease, 2017 - 2028 (USD Million)

12.4.12.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.4.12.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.4.12.2    Market size, by product, 2017 - 2028 (USD Million)

12.4.12.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.4.12.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.4.12.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.4.12.3    Market size, by patient, 2017 - 2028 (USD Million)

12.4.12.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.4.12.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.4.12.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.4.12.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.4.12.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.4.12.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.4.12.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.4.13    Australia

12.4.13.1    Market size, by disease, 2017 - 2028 (USD Million)

12.4.13.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.4.13.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.4.13.2    Market size, by product, 2017 - 2028 (USD Million)

12.4.13.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.4.13.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.4.13.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.4.13.3    Market size, by patient, 2017 - 2028 (USD Million)

12.4.13.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.4.13.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.4.13.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.4.13.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.4.13.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.4.13.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.4.13.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.4.14    South Korea

12.4.14.1    Market size, by disease, 2017 - 2028 (USD Million)

12.4.14.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.4.14.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.4.14.2    Market size, by product, 2017 - 2028 (USD Million)

12.4.14.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.4.14.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.4.14.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.4.14.3    Market size, by patient, 2017 - 2028 (USD Million)

12.4.14.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.4.14.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.4.14.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.4.14.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.4.14.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.4.14.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.4.14.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.5    Latin America

12.5.1    Market size, by country, 2017 - 2028 (USD Million)

12.5.2    Market size, by disease, 2017 - 2028 (USD Million)

12.5.2.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.5.2.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.5.3    Market size, by product, 2017 - 2028 (USD Million)

12.5.3.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.5.3.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.5.3.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.5.4    Market size, by patient, 2017 - 2028 (USD Million)

12.5.4.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.5.4.2    Market size, by adult, 2017 - 2028 (USD Million)

12.5.5    Market size, by treatment, 2017 - 2028 (USD Million)

12.5.6    Market size, by therapy, 2017 - 2028 (USD Million)

12.5.7    Market size, by drug class, 2017 - 2028 (USD Million)

12.5.8    Market size, by route of administration, 2017 - 2028 (USD Million)

12.5.9    Market size, by end-use, 2017 - 2028 (USD Million)

12.5.10    Brazil

12.5.10.1    Market size, by disease, 2017 - 2028 (USD Million)

12.5.10.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.5.10.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.5.10.2    Market size, by product, 2017 - 2028 (USD Million)

12.5.10.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.5.10.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.5.10.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.5.10.3    Market size, by patient, 2017 - 2028 (USD Million)

12.5.10.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.5.10.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.5.10.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.5.10.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.5.10.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.5.10.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.5.10.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.5.11    Mexico

12.5.11.1    Market size, by disease, 2017 - 2028 (USD Million)

12.5.11.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.5.11.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.5.11.2    Market size, by product, 2017 - 2028 (USD Million)

12.5.11.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.5.11.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.5.11.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.5.11.3    Market size, by patient, 2017 - 2028 (USD Million)

12.5.11.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.5.11.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.5.11.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.5.11.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.5.11.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.5.11.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.5.11.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.5.12    Argentina

12.5.12.1    Market size, by disease, 2017 - 2028 (USD Million)

12.5.12.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.5.12.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.5.12.2    Market size, by product, 2017 - 2028 (USD Million)

12.5.12.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.5.12.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.5.12.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.5.12.3    Market size, by patient, 2017 - 2028 (USD Million)

12.5.12.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.5.12.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.5.12.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.5.12.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.5.12.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.5.12.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.5.12.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.6    Middle East and Africa

12.6.1    Market size, by country, 2017 - 2028 (USD Million)

12.6.2    Market size, by disease, 2017 - 2028 (USD Million)

12.6.2.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.6.2.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.6.3    Market size, by product, 2017 - 2028 (USD Million)

12.6.3.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.6.3.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.6.3.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.6.4    Market size, by patient, 2017 - 2028 (USD Million)

12.6.4.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.6.4.2    Market size, by adult, 2017 - 2028 (USD Million)

12.6.5    Market size, by treatment, 2017 - 2028 (USD Million)

12.6.6    Market size, by therapy, 2017 - 2028 (USD Million)

12.6.7    Market size, by drug class, 2017 - 2028 (USD Million)

12.6.8    Market size, by route of administration, 2017 - 2028 (USD Million)

12.6.9    Market size, by end-use, 2017 - 2028 (USD Million)

12.6.10    South Africa

12.6.10.1    Market size, by disease, 2017 - 2028 (USD Million)

12.6.10.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.6.10.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.6.10.2    Market size, by product, 2017 - 2028 (USD Million)

12.6.10.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.6.10.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.6.10.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.6.10.3    Market size, by patient, 2017 - 2028 (USD Million)

12.6.10.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.6.10.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.6.10.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.6.10.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.6.10.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.6.10.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.6.10.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.6.11    Saudi Arabia

12.6.11.1    Market size, by disease, 2017 - 2028 (USD Million)

12.6.11.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.6.11.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.6.11.2    Market size, by product, 2017 - 2028 (USD Million)

12.6.11.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.6.11.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.6.11.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.6.11.3    Market size, by patient, 2017 - 2028 (USD Million)

12.6.11.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.6.11.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.6.11.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.6.11.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.6.11.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.6.11.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.6.11.8    Market size, by end-use, 2017 - 2028 (USD Million)

12.6.12    UAE

12.6.12.1    Market size, by disease, 2017 - 2028 (USD Million)

12.6.12.1.1    Market size, by hemophilia A, 2017 - 2028 (USD Million)

12.6.12.1.2    Market size, by hemophilia B, 2017 - 2028 (USD Million)

12.6.12.2    Market size, by product, 2017 - 2028 (USD Million)

12.6.12.2.1    Market size, by recombinant factor concentrates, 2017 - 2028 (USD Million)

12.6.12.2.2    Market size, by plasma-derived factor concentrates, 2017 - 2028 (USD Million)

12.6.12.2.3    Market size, by extended half-life products, 2017 - 2028 (USD Million)

12.6.12.3    Market size, by patient, 2017 - 2028 (USD Million)

12.6.12.3.1    Market size, by pediatric, 2017 - 2028 (USD Million)

12.6.12.3.2    Market size, by adult, 2017 - 2028 (USD Million)

12.6.12.4    Market size, by treatment, 2017 - 2028 (USD Million)

12.6.12.5    Market size, by therapy, 2017 - 2028 (USD Million)

12.6.12.6    Market size, by drug class, 2017 - 2028 (USD Million)

12.6.12.7    Market size, by route of administration, 2017 - 2028 (USD Million)

12.6.12.8    Market size, by end-use, 2017 - 2028 (USD Million)

Chapter 13   Company Profiles

13.1    Competitive dashboard, 2021

13.2    Bayer Healthcare

13.2.1    Business overview

13.2.2    Financial data

13.2.3    Product landscape

13.2.4    Strategic outlook

13.2.5    SWOT analysis

13.3    Biogen

13.3.1    Business overview

13.3.2    Financial data

13.3.3    Product landscape

13.3.4    Strategic outlook

13.3.5    SWOT analysis

13.4    Biotest AG

13.4.1    Business overview

13.4.2    Financial data

13.4.3    Product landscape

13.4.4    Strategic outlook

13.4.5    SWOT analysis

13.5    CSL Behring

13.5.1    Business overview

13.5.2    Financial data

13.5.3    Product landscape

13.5.4    Strategic outlook

13.5.5    SWOT analysis

13.6    Ferring B.V.

13.6.1    Business overview

13.6.2    Financial data

13.6.3    Product landscape

13.6.4    Strategic outlook

13.6.5    SWOT analysis

13.7    Genentech

13.7.1    Business overview

13.7.2    Financial data

13.7.3    Product landscape

13.7.4    Strategic outlook

13.7.5    SWOT analysis

13.8    Kedrion

13.8.1    Business overview

13.8.2    Financial data

13.8.3    Product landscape

13.8.4    Strategic outlook

13.8.5    SWOT analysis

13.9    Novo Nordisk

13.9.1    Business overview

13.9.2    Financial data

13.9.3    Product landscape

13.9.4    Strategic outlook

13.9.5    SWOT analysis

13.10    Octapharma

13.10.1    Business overview

13.10.2    Financial data

13.10.3    Product landscape

13.10.4    Strategic outlook

13.10.5    SWOT analysis

13.11    Pfizer

13.11.1    Business overview

13.11.2    Financial data

13.11.3    Product landscape

13.11.4    Strategic outlook

13.11.5    SWOT analysis

13.12    Sanofi SA

13.12.1    Business overview

13.12.2    Financial data

13.12.3    Product landscape

13.12.4    Strategic outlook

13.12.5    SWOT analysis

13.13    Swedish Orphan Biovitrum AB

13.13.1    Business overview

13.13.2    Financial data

13.13.3    Product landscape

13.13.4    Strategic outlook

13.13.5    SWOT analysis
 

Data Tables

TABLE.1    Global hemophilia treatment market size, 2017 - 2021, (USD Million)

TABLE.2    Global hemophilia treatment market size, 2022 - 2028, (USD Million)

TABLE.3    Global hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.4    Global hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.5    Global hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.6    Global hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.7    Global hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.8    Global hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.9    Global hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.10    Global hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.11    Global hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.12    Global hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.13    Global hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.14    Global hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.15    Global hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.16    Global hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.17    Global hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.18    Global hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.19    Industry impact forces

TABLE.20    Hemophilia A market size, by region, 2017 – 2021 (USD Million)

TABLE.21    Hemophilia A market size, by region, 2022 - 2028 (USD Million)

TABLE.22    Severe market size, by region, 2017 – 2021 (USD Million)

TABLE.23    Severe market size, by region, 2022 - 2028 (USD Million)

TABLE.24    Moderate market size, by region, 2017 – 2021 (USD Million)

TABLE.25    Moderate market size, by region, 2022 - 2028 (USD Million)

TABLE.26    Mild market size, by region, 2017 – 2021 (USD Million)

TABLE.27    Mild market size, by region, 2022 - 2028 (USD Million)

TABLE.28    Hemophilia B market size, by region, 2017 – 2021 (USD Million)

TABLE.29    Hemophilia B market size, by region, 2022 - 2028 (USD Million)

TABLE.30    Severe market size, by region, 2017 – 2021 (USD Million)

TABLE.31    Severe market size, by region, 2022 - 2028 (USD Million)

TABLE.32    Moderate market size, by region, 2017 – 2021 (USD Million)

TABLE.33    Moderate market size, by region, 2022 - 2028 (USD Million)

TABLE.34    Mild market size, by region, 2017 – 2021 (USD Million)

TABLE.35    Mild market size, by region, 2022 - 2028 (USD Million)

TABLE.36    Recombinant factor concentrates market size, by region, 2017 – 2021 (USD Million)

TABLE.37    Recombinant factor concentrates market size, by region, 2022 - 2028 (USD Million)

TABLE.38    Factor VIII market size, by region, 2017 – 2021 (USD Million)

TABLE.39    Factor VIII market size, by region, 2022 - 2028 (USD Million)

TABLE.40    Factor IX market size, by region, 2017 – 2021 (USD Million)

TABLE.41    Factor IX market size, by region, 2022 - 2028 (USD Million)

TABLE.42    Plasma-derived factor concentrates market size, by region, 2017 – 2021 (USD Million)

TABLE.43    Plasma-derived factor concentrates market size, by region, 2022 - 2028 (USD Million)

TABLE.44    Factor VIII market size, by region, 2017 – 2021 (USD Million)

TABLE.45    Factor IX market size, by region, 2022 - 2028 (USD Million)

TABLE.46    Extended half-life products market size, by region, 2017 – 2021 (USD Million)

TABLE.47    Extended half-life products market size, by region, 2022 - 2028 (USD Million)

TABLE.48    Factor VIII market size, by region, 2017 – 2021 (USD Million)

TABLE.49    Factor VIII market size, by region, 2022 - 2028 (USD Million)

TABLE.50    Factor IX market size, by region, 2017 – 2021 (USD Million)

TABLE.51    Factor IX market size, by region, 2022 - 2028 (USD Million)

TABLE.52    Others market size, by region, 2017 - 2021 (USD Million)

TABLE.53    Others market size, by region, 2022 - 2028 (USD Million)

TABLE.54    Pediatric market size, by region, 2017 – 2021 (USD Million)

TABLE.55    Pediatric market size, by region, 2022 - 2028 (USD Million)

TABLE.56    0 to 4 market size, by region, 2017 – 2021 (USD Million)

TABLE.57    0 to 4 market size, by region, 2022 - 2028 (USD Million)

TABLE.58    5 to 13 market size, by region, 2017 – 2021 (USD Million)

TABLE.59    5 to 13 market size, by region, 2022 - 2028 (USD Million)

TABLE.60    14 to18 market size, by region, 2017 – 2021 (USD Million)

TABLE.61    14 to18 market size, by region, 2022 - 2028 (USD Million)

TABLE.62    Adult market size, by region, 2017 – 2021 (USD Million)

TABLE.63    Adult market size, by region, 2022 - 2028 (USD Million)

TABLE.64    19 to 44 market size, by region, 2017 – 2021 (USD Million)

TABLE.65    19 to 44 market size, by region, 2022 - 2028 (USD Million)

TABLE.66    45+ market size, by region, 2017 – 2021 (USD Million)

TABLE.67    45+ market size, by region, 2022 - 2028 (USD Million)

TABLE.68    Prophylaxis market size, by region, 2017 – 2021 (USD Million)

TABLE.69    Prophylaxis market size, by region, 2022 - 2028 (USD Million)

TABLE.70    On demand market size, by region, 2017 – 2021 (USD Million)

TABLE.71    On demand market size, by region, 2022 - 2028 (USD Million)

TABLE.72    Factor replacement therapy market size, by region, 2017 – 2021 (USD Million)

TABLE.73    Factor replacement therapy market size, by region, 2022 - 2028 (USD Million)

TABLE.74    Non-factor replacement therapy market size, by region, 2017 – 2021 (USD Million)

TABLE.75    Non-factor replacement therapy market size, by region, 2022 - 2028 (USD Million)

TABLE.76    Vasopressin market size, by region, 2017 – 2021 (USD Million)

TABLE.77    Vasopressin market size, by region, 2022 - 2028 (USD Million)

TABLE.78    Coagulation factors market size, by region, 2017 – 2021 (USD Million)

TABLE.79    Coagulation factors market size, by region, 2022 - 2028 (USD Million)

TABLE.80    Injectable market size, by region, 2017 – 2021 (USD Million)

TABLE.81    Injectable market size, by region, 2022 - 2028 (USD Million)

TABLE.82    Nasal spray market size, by region, 2017 – 2021 (USD Million)

TABLE.83    Nasal spray market size, by region, 2022 - 2028 (USD Million)

TABLE.84    Hospitals market size, by region, 2017 – 2021 (USD Million)

TABLE.85    Hospitals market size, by region, 2022 - 2028 (USD Million)

TABLE.86    Clinics market size, by region, 2017 – 2021 (USD Million)

TABLE.87    Clinics market size, by region, 2022 - 2028 (USD Million)

TABLE.88    Hemophilia treatment centers market size, by region, 2017 – 2021 (USD Million)

TABLE.89    Hemophilia treatment centers market size, by region, 2022 - 2028 (USD Million)

TABLE.90    Others market size, by region, 2017 - 2021 (USD Million)

TABLE.91    Others market size, by region, 2022 - 2028 (USD Million)

TABLE.92    North America hemophilia treatment market size, by country, 2017 - 2021 (USD Million)

TABLE.93    North America hemophilia treatment market size, by country, 2022 - 2028 (USD Million)

TABLE.94    North America hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.95    North America hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.96    North America hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.97    North America hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.98    North America hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.99    North America hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.100    North America hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.101    North America hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.102    North America hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.103    North America hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.104    North America hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.105    North America hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.106    North America hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.107    North America hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.108    North America hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.109    North America hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.110    North America hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.111    North America hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.112    North America hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.113    North America hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.114    North America hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.115    North America hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.116    North America hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.117    North America hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.118    North America hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.119    North America hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.120    North America hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.121    North America hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.122    North America hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.123    North America hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.124    U.S. hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.125    U.S. hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.126    U.S. hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.127    U.S. hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.128    U.S. hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.129    U.S. hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.130    U.S. hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.131    U.S. hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.132    U.S. hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.133    U.S. hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.134    U.S. hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.135    U.S. hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.136    U.S. hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.137    U.S. hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.138    U.S. hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.139    U.S. hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.140    U.S. hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.141    U.S. hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.142    U.S. hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.143    U.S. hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.144    U.S. hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.145    U.S. hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.146    U.S. hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.147    U.S. hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.148    U.S. hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.149    U.S. hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.150    U.S. hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.151    U.S. hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.152    U.S. hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.153    U.S. hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.154    Canada hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.155    Canada hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.156    Canada hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.157    Canada hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.158    Canada hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.159    Canada hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.160    Canada hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.161    Canada hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.162    Canada hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.163    Canada hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.164    Canada hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.165    Canada hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.166    Canada hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.167    Canada hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.168    Canada hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.169    Canada hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.170    Canada hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.171    Canada hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.172    Canada hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.173    Canada hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.174    Canada hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.175    Canada hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.176    Canada hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.177    Canada hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.178    Canada hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.179    Canada hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.180    Canada hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.181    Canada hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.182    Canada hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.183    Canada hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.184    Europe hemophilia treatment market size, by country, 2017 - 2021 (USD Million)

TABLE.185    Europe hemophilia treatment market size, by country, 2022 - 2028 (USD Million)

TABLE.186    Europe hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.187    Europe hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.188    Europe hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.189    Europe hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.190    Europe hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.191    Europe hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.192    Europe hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.193    Europe hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.194    Europe hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.195    Europe hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.196    Europe hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.197    Europe hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.198    Europe hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.199    Europe hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.200    Europe hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.201    Europe hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.202    Europe hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.203    Europe hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.204    Europe hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.205    Europe hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.206    Europe hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.207    Europe hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.208    Europe hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.209    Europe hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.210    Europe hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.211    Europe hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.212    Europe hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.213    Europe hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.214    Europe hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.215    Europe hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.216    Germany hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.217    Germany hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.218    Germany hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.219    Germany hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.220    Germany hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.221    Germany hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.222    Germany hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.223    Germany hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.224    Germany hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.225    Germany hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.226    Germany hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.227    Germany hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.228    Germany hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.229    Germany hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.230    Germany hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.231    Germany hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.232    Germany hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.233    Germany hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.234    Germany hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.235    Germany hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.236    Germany hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.237    Germany hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.238    Germany hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.239    Germany hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.240    Germany hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.241    Germany hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.242    Germany hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.243    Germany hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.244    Germany hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.245    Germany hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.246    UK hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.247    UK hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.248    UK hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.249    UK hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.250    UK hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.251    UK hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.252    UK hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.253    UK hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.254    UK hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.255    UK hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.256    UK hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.257    UK hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.258    UK hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.259    UK hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.260    UK hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.261    UK hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.262    UK hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.263    UK hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.264    UK hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.265    UK hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.266    UK hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.267    UK hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.268    UK hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.269    UK hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.270    UK hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.271    UK hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.272    UK hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.273    UK hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.274    UK hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.275    UK hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.276    France hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.277    France hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.278    France hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.279    France hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.280    France hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.281    France hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.282    France hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.283    France hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.284    France hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.285    France hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.286    France hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.287    France hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.288    France hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.289    France hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.290    France hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.291    France hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.292    France hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.293    France hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.294    France hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.295    France hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.296    France hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.297    France hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.298    France hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.299    France hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.300    France hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.301    France hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.302    France hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.303    France hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.304    France hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.305    France hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.306    Spain hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.307    Spain hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.308    Spain hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.309    Spain hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.310    Spain hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.311    Spain hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.312    Spain hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.313    Spain hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.314    Spain hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.315    Spain hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.316    Spain hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.317    Spain hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.318    Spain hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.319    Spain hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.320    Spain hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.321    Spain hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.322    Spain hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.323    Spain hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.324    Spain hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.325    Spain hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.326    Spain hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.327    Spain hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.328    Spain hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.329    Spain hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.330    Spain hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.331    Spain hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.332    Spain hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.333    Spain hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.334    Spain hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.335    Spain hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.336    Italy hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.337    Italy hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.338    Italy hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.339    Italy hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.340    Italy hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.341    Italy hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.342    Italy hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.343    Italy hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.344    Italy hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.345    Italy hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.346    Italy hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.347    Italy hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.348    Italy hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.349    Italy hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.350    Italy hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.351    Italy hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.352    Italy hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.353    Italy hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.354    Italy hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.355    Italy hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.356    Italy hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.357    Italy hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.358    Italy hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.359    Italy hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.360    Italy hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.361    Italy hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.362    Italy hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.363    Italy hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.364    Italy hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.365    Italy hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.366    Asia Pacific hemophilia treatment market size, by country, 2017 - 2021 (USD Million)

TABLE.367    Asia Pacific hemophilia treatment market size, by country, 2022 - 2028 (USD Million)

TABLE.368    Asia Pacific hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.369    Asia Pacific hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.370    Asia Pacific hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.371    Asia Pacific hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.372    Asia Pacific hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.373    Asia Pacific hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.374    Asia Pacific hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.375    Asia Pacific hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.376    Asia Pacific hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.377    Asia Pacific hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.378    Asia Pacific hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.379    Asia Pacific hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.380    Asia Pacific hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.381    Asia Pacific hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.382    Asia Pacific hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.383    Asia Pacific hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.384    Asia Pacific hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.385    Asia Pacific hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.386    Asia Pacific hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.387    Asia Pacific hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.388    Asia Pacific hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.389    Asia Pacific hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.390    Asia Pacific hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.391    Asia Pacific hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.392    Asia Pacific hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.393    Asia Pacific hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.394    Asia Pacific hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.395    Asia Pacific hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.396    Asia Pacific hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.397    Asia Pacific hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.398    China hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.399    China hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.400    China hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.401    China hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.402    China hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.403    China hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.404    China hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.405    China hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.406    China hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.407    China hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.408    China hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.409    China hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.410    China hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.411    China hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.412    China hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.413    China hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.414    China hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.415    China hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.416    China hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.417    China hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.418    China hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.419    China hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.420    China hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.421    China hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.422    China hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.423    China hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.424    China hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.425    China hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.426    China hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.427    China hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.428    Japan hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.429    Japan hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.430    Japan hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.431    Japan hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.432    Japan hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.433    Japan hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.434    Japan hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.435    Japan hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.436    Japan hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.437    Japan hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.438    Japan hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.439    Japan hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.440    Japan hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.441    Japan hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.442    Japan hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.443    Japan hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.444    Japan hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.445    Japan hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.446    Japan hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.447    Japan hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.448    Japan hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.449    Japan hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.450    Japan hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.451    Japan hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.452    Japan hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.453    Japan hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.454    Japan hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.455    Japan hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.456    Japan hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.457    Japan hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.458    India hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.459    India hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.460    India hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.461    India hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.462    India hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.463    India hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.464    India hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.465    India hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.466    India hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.467    India hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.468    India hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.469    India hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.470    India hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.471    India hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.472    India hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.473    India hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.474    India hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.475    India hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.476    India hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.477    India hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.478    India hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.479    India hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.480    India hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.481    India hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.482    India hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.483    India hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.484    India hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.485    India hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.486    India hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.487    India hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.488    Australia hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.489    Australia hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.490    Australia hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.491    Australia hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.492    Australia hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.493    Australia hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.494    Australia hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.495    Australia hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.496    Australia hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.497    Australia hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.498    Australia hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.499    Australia hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.500    Australia hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.501    Australia hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.502    Australia hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.503    Australia hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.504    Australia hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.505    Australia hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.506    Australia hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.507    Australia hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.508    Australia hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.509    Australia hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.510    Australia hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.511    Australia hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.512    Australia hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.513    Australia hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.514    Australia hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.515    Australia hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.516    Australia hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.517    Australia hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.518    South Korea hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.519    South Korea hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.520    South Korea hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.521    South Korea hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.522    South Korea hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.523    South Korea hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.524    South Korea hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.525    South Korea hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.526    South Korea hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.527    South Korea hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.528    South Korea hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.529    South Korea hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.530    South Korea hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.531    South Korea hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.532    South Korea hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.533    South Korea hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.534    South Korea hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.535    South Korea hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.536    South Korea hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.537    South Korea hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.538    South Korea hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.539    South Korea hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.540    South Korea hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.541    South Korea hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.542    South Korea hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.543    South Korea hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.544    South Korea hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.545    South Korea hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.546    South Korea hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.547    South Korea hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.548    Latin America hemophilia treatment market size, by country, 2017 - 2021 (USD Million)

TABLE.549    Latin America hemophilia treatment market size, by country, 2022 - 2028 (USD Million)

TABLE.550    Latin America hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.551    Latin America hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.552    Latin America hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.553    Latin America hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.554    Latin America hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.555    Latin America hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.556    Latin America hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.557    Latin America hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.558    Latin America hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.559    Latin America hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.560    Latin America hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.561    Latin America hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.562    Latin America hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.563    Latin America hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.564    Latin America hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.565    Latin America hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.566    Latin America hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.567    Latin America hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.568    Latin America hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.569    Latin America hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.570    Latin America hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.571    Latin America hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.572    Latin America hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.573    Latin America hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.574    Latin America hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.575    Latin America hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.576    Latin America hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.577    Latin America hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.578    Latin America hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.579    Latin America hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.580    Brazil hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.581    Brazil hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.582    Brazil hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.583    Brazil hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.584    Brazil hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.585    Brazil hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.586    Brazil hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.587    Brazil hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.588    Brazil hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.589    Brazil hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.590    Brazil hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.591    Brazil hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.592    Brazil hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.593    Brazil hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.594    Brazil hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.595    Brazil hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.596    Brazil hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.597    Brazil hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.598    Brazil hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.599    Brazil hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.600    Brazil hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.601    Brazil hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.602    Brazil hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.603    Brazil hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.604    Brazil hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.605    Brazil hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.606    Brazil hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.607    Brazil hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.608    Brazil hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.609    Brazil hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.610    Mexico hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.611    Mexico hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.612    Mexico hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.613    Mexico hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.614    Mexico hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.615    Mexico hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.616    Mexico hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.617    Mexico hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.618    Mexico hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.619    Mexico hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.620    Mexico hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.621    Mexico hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.622    Mexico hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.623    Mexico hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.624    Mexico hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.625    Mexico hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.626    Mexico hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.627    Mexico hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.628    Mexico hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.629    Mexico hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.630    Mexico hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.631    Mexico hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.632    Mexico hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.633    Mexico hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.634    Mexico hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.635    Mexico hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.636    Mexico hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.637    Mexico hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.638    Mexico hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.639    Mexico hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.640    Argentina hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.641    Argentina hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.642    Argentina hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.643    Argentina hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.644    Argentina hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.645    Argentina hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.646    Argentina hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.647    Argentina hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.648    Argentina hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.649    Argentina hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.650    Argentina hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.651    Argentina hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.652    Argentina hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.653    Argentina hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.654    Argentina hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.655    Argentina hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.656    Argentina hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.657    Argentina hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.658    Argentina hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.659    Argentina hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.660    Argentina hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.661    Argentina hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.662    Argentina hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.663    Argentina hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.664    Argentina hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.665    Argentina hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.666    Argentina hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.667    Argentina hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.668    Argentina hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.669    Argentina hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.670    MEA hemophilia treatment market size, by country, 2017 - 2021 (USD Million)

TABLE.671    MEA hemophilia treatment market size, by country, 2022 - 2028 (USD Million)

TABLE.672    MEA hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.673    MEA hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.674    MEA hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.675    MEA hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.676    MEA hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.677    MEA hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.678    MEA hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.679    MEA hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.680    MEA hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.681    MEA hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.682    MEA hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.683    MEA hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.684    MEA hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.685    MEA hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.686    MEA hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.687    MEA hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.688    MEA hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.689    MEA hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.690    MEA hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.691    MEA hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.692    MEA hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.693    MEA hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.694    MEA hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.695    MEA hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.696    MEA hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.697    MEA hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.698    MEA hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.699    MEA hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.700    MEA hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.701    MEA hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.702    South Africa hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.703    South Africa hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.704    South Africa hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.705    South Africa hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.706    South Africa hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.707    South Africa hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.708    South Africa hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.709    South Africa hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.710    South Africa hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.711    South Africa hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.712    South Africa hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.713    South Africa hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.714    South Africa hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.715    South Africa hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.716    South Africa hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.717    South Africa hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.718    South Africa hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.719    South Africa hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.720    South Africa hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.721    South Africa hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.722    South Africa hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.723    South Africa hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.724    South Africa hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.725    South Africa hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.726    South Africa hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.727    South Africa hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.728    South Africa hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.729    South Africa hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.730    South Africa hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.731    South Africa hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.732    Saudi Arabia hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.733    Saudi Arabia hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.734    Saudi Arabia hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.735    Saudi Arabia hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.736    Saudi Arabia hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.737    Saudi Arabia hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.738    Saudi Arabia hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.739    Saudi Arabia hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.740    Saudi Arabia hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.741    Saudi Arabia hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.742    Saudi Arabia hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.743    Saudi Arabia hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.744    Saudi Arabia hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.745    Saudi Arabia hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.746    Saudi Arabia hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.747    Saudi Arabia hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.748    Saudi Arabia hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.749    Saudi Arabia hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.750    Saudi Arabia hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.751    Saudi Arabia hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.752    Saudi Arabia hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.753    Saudi Arabia hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.754    Saudi Arabia hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.755    Saudi Arabia hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.756    Saudi Arabia hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.757    Saudi Arabia hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.758    Saudi Arabia hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.759    Saudi Arabia hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.760    Saudi Arabia hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.761    Saudi Arabia hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)

TABLE.762    UAE hemophilia treatment market size, by disease, 2017 - 2021 (USD Million)

TABLE.763    UAE hemophilia treatment market size, by disease, 2022 - 2028 (USD Million)

TABLE.764    UAE hemophilia treatment market size, by hemophilia A, 2017 - 2021 (USD Million)

TABLE.765    UAE hemophilia treatment market size, by hemophilia A, 2022 - 2028 (USD Million)

TABLE.766    UAE hemophilia treatment market size, by hemophilia B, 2017 - 2021 (USD Million)

TABLE.767    UAE hemophilia treatment market size, by hemophilia B, 2022 - 2028 (USD Million)

TABLE.768    UAE hemophilia treatment market size, by product, 2017 - 2021 (USD Million)

TABLE.769    UAE hemophilia treatment market size, by product, 2022 - 2028 (USD Million)

TABLE.770    UAE hemophilia treatment market size, by recombinant factor concentrates, 2017 - 2021 (USD Million)

TABLE.771    UAE hemophilia treatment market size, by recombinant factor concentrates, 2022 - 2028 (USD Million)

TABLE.772    UAE hemophilia treatment market size, by plasma-derived factor concentrates, 2017 - 2021 (USD Million)

TABLE.773    UAE hemophilia treatment market size, by plasma-derived factor concentrates, 2022 - 2028 (USD Million)

TABLE.774    UAE hemophilia treatment market size, by extended half-life products, 2017 - 2021 (USD Million)

TABLE.775    UAE hemophilia treatment market size, by extended half-life products, 2022 - 2028 (USD Million)

TABLE.776    UAE hemophilia treatment market size, by patient, 2017 - 2021 (USD Million)

TABLE.777    UAE hemophilia treatment market size, by patient, 2022 - 2028 (USD Million)

TABLE.778    UAE hemophilia treatment market size, by pediatric, 2017 - 2021 (USD Million)

TABLE.779    UAE hemophilia treatment market size, by pediatric, 2022 - 2028 (USD Million)

TABLE.780    UAE hemophilia treatment market size, by adult, 2017 - 2021 (USD Million)

TABLE.781    UAE hemophilia treatment market size, by adult, 2022 - 2028 (USD Million)

TABLE.782    UAE hemophilia treatment market size, by treatment, 2017 - 2021 (USD Million)

TABLE.783    UAE hemophilia treatment market size, by treatment, 2022 - 2028 (USD Million)

TABLE.784    UAE hemophilia treatment market size, by therapy, 2017 - 2021 (USD Million)

TABLE.785    UAE hemophilia treatment market size, by therapy, 2022 - 2028 (USD Million)

TABLE.786    UAE hemophilia treatment market size, by drug class, 2017 - 2021 (USD Million)

TABLE.787    UAE hemophilia treatment market size, by drug class, 2022 - 2028 (USD Million)

TABLE.788    UAE hemophilia treatment market size, by route of administration, 2017 - 2021 (USD Million)

TABLE.789    UAE hemophilia treatment market size, by route of administration, 2022 - 2028 (USD Million)

TABLE.790    UAE hemophilia treatment market size, by end-use, 2017 - 2021 (USD Million)

TABLE.791    UAE hemophilia treatment market size, by end-use, 2022 - 2028 (USD Million)
 

Charts & Figures

FIG. 1    Top-down approach (supply side analysis)

FIG. 2    Industry segmentation

FIG. 3    Global hemophilia treatment market size, 2017 – 2028 (USD Million)

FIG. 4    Growth potential analysis, by disease

FIG. 5    Growth potential analysis, by product

FIG. 6    Growth potential analysis, by patient

FIG. 7    Growth potential analysis, by treatment

FIG. 8    Growth potential analysis, by therapy

FIG. 9    Growth potential analysis, by drug class

FIG. 10    Growth potential analysis, by route of administration

FIG. 11    Growth potential analysis, by end-use

FIG. 12    Porter’s analysis

FIG. 13    Competitive matrix analysis, 2021

FIG. 14    PESTEL analysis

FIG. 15    Key segment trends, by disease

FIG. 16    Key segment trends, by product

FIG. 17    Key segment trends, by patient

FIG. 18    Key segment trends, by treatment

FIG. 19    Key segment trends, by therapy

FIG. 20    Key segment trends, by drug class

FIG. 21    Key segment trends, by route of administration

FIG. 22    Key segment trends, by end-use

FIG. 23    Key regional trends

FIG. 24    Competitive dashboard, 2021

   

Authors: Sumant Ugalmugle, Rupali Swain

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2021
  • Companies covered: 12
  • Tables & Figures: 815
  • Countries covered: 18
  • Pages: 350

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount